|
Lantheus Medical Imaging has signed a new manufacturing and supply agreement with MDS Nordion to purchase molybdenum-99 (Mo-99), the parent isotope of technetium-99m.
Thursday, February 11 2010
MDS, a provider of products and services to the global life sciences markets, has signed agreements to divest its remaining MDS Pharma Services early-stage business, which provides discovery through Phase IIa clinical trial services to biotechnology and pharmaceutical companies, for $45 million and certain minority equity interests.
MDS has signed an agreement to sell its Central Labs operation, which conducts analysis of samples from late-stage clinical trials to Czura Thornton, an investment group based in Jersey, U.K.
MDS, a provider of products and services to the global life sciences markets, has entered into an agreement to sell its MDS Analytical Technologies business, a supplier of drug discovery and life sciences research tools, to Danaher of Washington, D.C., for $650 million in cash.
MDS Nordion, a medical isotope and radiopharmaceutical provider, is urging the Canadian government and Atomic Energy of Canada Limited to complete the Multipurpose Applied Physics Lattice Experiment (MAPLE) project to address the global shortage of medical isotopes. The company's statement is particularly compelling following the AECL announcement Wednesday that the 52-year-old National Research Universal (NRU) reactor at Chalk River, Ont., will not return to service before late 2009.
MDS Nordion, a provider of medical isotopes and radiopharmaceuticals, has formed an agreement with the Karpov Institute of Physical Chemistry in Moscow to study the feasibility of the Institute to provide MDS with a supply of molybdenum-99 (Mo-99) for the nuclear medicine market.
MDS Nordion, a provider of medical isotopes and radiopharmaceuticals, is opening a facility in Fleurus, Belgium, for the production of the PET imaging tracer fluorodeoxyglucose (F-18 FDG).
Atomic Energy of Canada Limited reported that an unplanned National Research Universal (NRU) reactor shutdown on May 14 was safely conducted. The shutdown occurred due to a loss of electrical power in eastern Ontario and western Quebec.
Atomic Energy of Canada Limited (AECL) reported that the National Research Universal (NRU) reactor at Chalk River Laboratories in Ontario, Canada, was safely returned to service this week, following an unscheduled maintenance to extract medical isotope rods from the reactor.
|
MDS Nordion is partnering with Villepinte, France-based Guerbet and Caen, France-based Cyceron to develop new PET radiotracers for cancer diagnostics.
Life sciences company MDS has appointed Steve West, former president of MDS Nordion and chief operating officer of MDS, to the position of CEO of the parent company and member of its board of directors.
Life sciences product devloper MDS has appointed Steve West, president of medical isotope developer MDS Nordion, as its chief operating officer (COO).
MDS Nordion has submitted a proposal to a Canadian government panel on medical isotope and technetium-99m generator production, suggesting that its Multipurpose Applied Physics Lattice Experiment (MAPLE) medical isotope reactor project could become a reality through the adoption of new computer codes.
The leader of the Canadian province of Saskatchewan is seeking to build a nuclear reactor and transform his province into a producer of medical isotopes, the Globe and Mail reported this past weekend.
MDS Nordion is urging the Canadian government and Atomic Energy of Canada Limited to reactivate the MAPLE nuclear reactor project as part of a stategy to address the medical isotope shortage created by the shutdown of the National Research Universal reactor at Chalk River, Ontario.
Atomic Energy of Canada Limited (AECL) anticipates that the National Research Universal (NRU) reactor in Chalk River, Canada, will remain out of service for more than one month. Last Friday, AECL removed the remaining molybdenum-99 available for isotope production from the NRU reactor; and as a result, MDS Nordion expects the impact of the shutdown to be felt this week.
MDS Nordion, TRIUMF, Canada's national laboratory for particle and nuclear physics, and the University of British Columbia have entered into a three-year research and development partnership to pursue the development of new diagnostic imaging agents using technology based on radiometals and chelates.
|
RSS 
SNM, the American Society of Nuclear Cardiology, the American College of Cardiology and a coalition of medical and national security organizations have urged Sen. Christopher S. "Kit" Bond, R-Mo., to lift a "hold" on the American Medical Isotope Production Act (H.R. 3276), and permit a vote by the U.S. Senate, which passed the U.S. House of Representatives by a vote of 400-17. Several radiologists and nuclear medicine specialists spoke to their concerns if the U.S. continues to rely on foreign sources for medical isotopes.
“We’re beginning a revolution the way information is collected, managed, used and purposed for patients in the U.S. healthcare system,” said David Blumenthal, MD, chair of the Office of the National Coordinator for Health IT, in opening remarks at an audioconference training session on meaningful use and EHR certification last week.
Single mammography reading with computer-aided detection (CAD) and double reading yielded similar cancer detection rates; however, each reading regimen helped radiologists detect cancers missed by the other, according to the CADET II study published in the August issue of Radiology.
In Part 1 of our closer look at the final rules for meaningful use and EHR certification standards, CMIO’s Jeff Byers spoke with David Blumenthal, MD, chair of the Office of the National Coordinator for Health IT. In Part 2, CMIOs weigh in with mixed reviews.
The framework for meaningful use is “something that had to be done and has been started intelligently,” John P. Glaser, PhD, vice president and CIO of Partners HealthCare System told CMIO. However, the challenges of becoming meaningful users and optimizing health information exchange will require unprecedented levels of communication within organizations and among healthcare systems, he said.
